Nucleophosmin 1 as A Cancer and Neurodegenerative Disease Research Target
Nucleophosmin 1 as A Cancer and Neurodegenerative Disease Research Target
Nucleophosmin 1 (NPM1P13) is a protein that is found in the nucleolus, which is the key structure in the nucleus of a cell. NPM1P13 plays a vital role in the proper functioning of the cell, and its levels have been linked to a number of diseases, including cancer.
One of the reasons that NPM1P13 has been identified as a potential drug target is its role in the development and progression of cancer. NPM1P13 has been shown to be highly expressed in a variety of cancer types, including breast, ovarian, and prostate cancer. Additionally, studies have shown that inhibiting NPM1P13 can lead to a reduction in cancer cell proliferation and the formation of new blood vessels, which can be a promising approach to cancer treatment.
Another potential mechanism by which NPM1P13 may be targeted as a drug is its role in the regulation of cell death. NPM1P13 has been shown to play a role in the production of the protein Apoptosis-associated protein-1 (AP-1), which is involved in cell death. Additionally, studies have shown that inhibiting NPM1P13 can lead to increased levels of AP-1 and an increase in cell death, which may be a potential mechanism of action for a drug that targets NPM1P13.
In addition to its potential role as a drug target, NPM1P13 has also been identified as a potential biomarker for a number of diseases. For example, studies have shown that increased levels of NPM1P13 have been associated with the development of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, NPM1P13 has been shown to be highly expressed in a variety of tissues and fluids, which may make it a useful diagnostic marker for a number of conditions.
Overall, NPM1P13 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in the functioning of the cell and its potential as a therapeutic target.
Protein Name: Nucleophosmin 1 Pseudogene 13
The "NPM1P13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPM1P13 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NPM1P21 | NPM1P22 | NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2
